Sparsentan in Posttransplant Immunoglobulin A Nephropathy or Focal Segmental Glomerulosclerosis
Sparsentan in Posttransplant Immunoglobulin A Nephropathy or Focal Segmental Glomerulosclerosis
Active, not recruiting · NCT07219121 · Registry updated 2026-06-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Sparsentan in Posttransplant Immunoglobulin A Nephropathy or Focal Segmental Glomerulosclerosis | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urination Disorders, Urogenital Diseases, Urological Manifestations, focal segmental glomerulosclerosis, glomerulonephritis, kidney disorder, nephritis, proteinuria, urinary system disorder | Active, not recruiting | Phase 4 | 2026-06-23 | NCT07219121 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Travere Therapeutics, Inc. | 10 |
8 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cornell Medical Center | New York | United States | 1 |
| Dallas Nephrology Associates | Dallas | United States | 2 |
| Ohio State University | Columbus | United States | 169 |
| University of Alabama at Birmingham | Birmingham | United States | 247 |
| University of North Carolina Chapel Hill | Morrisville | United States | 1 |
| University of Texas | Galveston | United States | 1 |
| University of Washington | Seattle | United States | 172 |
| University of Wisconsin | Madison | United States | 64 |